Kerb's Cycle Associated Disorders

← Back to Index (Metabolic Disorders)

Definition And Pathophysiology

Classification And Specific Disorders

Disorder Genetics And Mechanism Biochemical Profile Clinical Phenotype
Alpha-Ketoglutarate Dehydrogenase Deficiency Mutations in the DLD gene affecting the E3 subunit (shared with PDH and BCKDH). Elevated alpha-ketoglutarate, lactate, pyruvate, and branched-chain ketoacids. Early infancy onset, progressive neurologic deterioration, hypotonia, ataxia, and Leigh syndrome.
Succinate Dehydrogenase (SDH) Deficiency Mutations in SDHA. Affects both the Krebs cycle and Complex II of the Electron Transport Chain. - Infantile Leigh syndrome, hypertrophic or dilated cardiomyopathy, and tumor predisposition (paragangliomas).
Succinyl-CoA Synthetase Deficiency Mutations in SUCLG1 or SUCLA2. Impairs nucleoside diphosphate kinase interaction. Mild methylmalonic aciduria. Severe encephalomyopathy, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like features, associated with mtDNA depletion.
Fumarase Deficiency Defect in Fumarate Hydratase. Massive excretion of fumaric acid and elevated succinate. Severe infantile encephalopathy, brain malformations (polymicrogyria), and facial dysmorphism.
Pyruvate Carboxylase (PC) Deficiency Anaplerotic defect preventing conversion of pyruvate to oxaloacetate. Elevated lactate, pyruvate, alanine, and ketones. Type B shows severe lactic acidosis, hyperammonemia, and hypercitrullinemia. Type A: lactic acidosis and developmental delay. Type B: neonatal coma, urea cycle failure, and early death. Type C: benign.

Clinical Features

System Manifestations
Neurologic Leigh syndrome, global developmental delay, regression of milestones, intractable epilepsy, and severe central hypotonia. Movement disorders include dystonia, ataxia, and choreoathetosis.
Cardiac Hypertrophic or dilated cardiomyopathy, particularly in SDH and Fumarase defects.
Hepatic And Metabolic Liver failure or dysfunction in PC deficiency. Recurrent severe high anion gap metabolic acidosis (lactic acidosis) triggered by catabolic stress.

Investigations

Screening And Metabolites

Test Diagnostic Findings
Initial Screen High anion gap metabolic acidosis, elevated lactate with increased Lactate:Pyruvate ratio (>20). Hypoglycemia is present in PC deficiency due to gluconeogenesis impairment.
Ammonia Elevated in PC deficiency Type B due to oxaloacetate depletion disrupting the urea cycle.
Urine Organic Acids Massive fumaric acid excretion (Fumarase deficiency). Elevated alpha-ketoglutarate and branched-chain hydroxyacids (Alpha-KGDH deficiency).

Neuroimaging And Confirmation

Management

Acute Management

Chronic Maintenance And Cofactors

Modality Rationale And Options
Dietary Modification High carbohydrate and protein diet is recommended for PC deficiency to prevent gluconeogenic stress.
Anaplerotic Therapy Triheptanoin (C7 oil) provides propionyl-CoA/succinyl-CoA to bypass early blocks. Aspartate and citrate supplementation replenishes the oxaloacetate pool in PC deficiency.
Cofactor Supplementation Thiamine (B1) targets Alpha-KGDH. Lipoic acid supplements E3 subunit defects. Biotin is essential for Pyruvate Carboxylase.